SCOLR, INC.Scolr Inc • August 13th, 2003 • In vitro & in vivo diagnostic substances
SCOLR, INC.Scolr Inc • August 13th, 2003 • In vitro & in vivo diagnostic substances
EXHIBIT 10.29 ADVISORY AGREEMENT This Advisory Agreement dated as of August 7, 2003 between SCOLR, Inc., a Delaware corporation (the "Company") and David T. Howard ("Howard"). WHEREAS, Howard has served as President and Chief Executive Officer of the...Advisory Agreement • August 13th, 2003 • Scolr Inc • In vitro & in vivo diagnostic substances • Washington
EXHIBIT 10.28 SEPARATION AGREEMENT THIS AGREEMENT ("Agreement") is entered into as of the 7th day of August, 2003, by and between SCOLR, Inc., a Delaware corporation (the "Company") and David T. Howard ("Howard") in order to provide the terms and...Separation Agreement • August 13th, 2003 • Scolr Inc • In vitro & in vivo diagnostic substances • Washington
SCOLR, INC.Scolr Inc • August 13th, 2003 • In vitro & in vivo diagnostic substances • Delaware
BACKGROUNDEmployment Agreement • August 13th, 2003 • Scolr Inc • In vitro & in vivo diagnostic substances • Washington
EXHIBIT 10.24 TERMINATION TO COMMERCIAL LEASE THIS TERMINATION TO COMMERCIAL LEASE is made this 24th day of July 2003, by and between DAVID H. VEBLEN/ MORTENSON TRUST (hereinafter "Landlord") and NUTRACEUTIX, INC. (hereinafter "Tenant"). WHEREAS,...Scolr Inc • August 13th, 2003 • In vitro & in vivo diagnostic substances
EXHIBIT 10.12 LICENSE AGREEMENT This Agreement is made effective this 22nd day of December, 1998 by and between Temple University - Of The Commonwealth System of Higher Education, a corporation organized and existing under the laws of the Commonwealth...License Agreement • August 13th, 2003 • Scolr Inc • In vitro & in vivo diagnostic substances • Pennsylvania
SCOLR, INC.Convertible Note Purchase Agreement • August 13th, 2003 • Scolr Inc • In vitro & in vivo diagnostic substances • Delaware
RECITALSIntellectual Property Assignment and Assumption Agreement • August 13th, 2003 • Scolr Inc • In vitro & in vivo diagnostic substances • Washington
EXHIBIT 10.19 ADDITIONAL SERVICES AGREEMENT This Additional Services Agreement ("Agreement") is made and entered into by and between Nutraceutix, Inc., a Delaware corporation ("Nutraceutix") and Dr. Reza Fassihi ("Dr. Fassihi"). This Agreement shall...Additional Services Agreement • August 13th, 2003 • Scolr Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.14 MASTER RESEARCH AND DEVELOPMENT AGREEMENT This Agreement is made effective this first day of May, 2001 by and between Temple University - Of The Commonwealth System of Higher Education, having a principal place of business at Broad...Master Research and Development Agreement • August 13th, 2003 • Scolr Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.17 LICENSE AGREEMENT This Agreement is made effective this first day of September, 2001 by and between Temple University - Of The Commonwealth System of Higher Education, a corporation organized and existing under the laws of the...License Agreement • August 13th, 2003 • Scolr Inc • In vitro & in vivo diagnostic substances • Pennsylvania
EXHIBIT 10.15 CONSULTING AGREEMENT This Agreement, dated as of December 22, 2000, is made and entered into by and between Nutraceutix, Inc., a Delaware corporation ("Nutraceutix") and Dr. Reza Fassihi ("Dr. Fassihi"). 1. Consulting. Nutraceutix hereby...Consulting Agreement • August 13th, 2003 • Scolr Inc • In vitro & in vivo diagnostic substances • Washington
EXHIBIT 10.13 LICENSE AGREEMENT This Agreement is made effective this 6th day of September, 2000 by and between Temple University - Of The Commonwealth System of Higher Education, a corporation organized and existing under the laws of the Commonwealth...License Agreement • August 13th, 2003 • Scolr Inc • In vitro & in vivo diagnostic substances • Pennsylvania
EXHIBIT 10.11 RESEARCH AND TRANSFER AGREEMENT This Agreement is made by and between Temple University - Of The Commonwealth System of Higher Education, having a principal place of business at Broad Street and Montgomery Avenue, Philadelphia,...Research and Transfer Agreement • August 13th, 2003 • Scolr Inc • In vitro & in vivo diagnostic substances
